SLX-0953 | Interleukin Related interleukin-related.com

Product Name :
SLX-0953

Search keywords :
PEG3

drugId :
null

Target Vo:
Maternal embryonic leucine zipper kinase

Target Vo Short Name :
MELK

Moa_Name:
Maternal embryonic leucine zipper kinase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Biolexis Therapeutics Inc

Active Company_Name :
Biolexis Therapeutics Inc

Active Indication_Name:
Precursor Cell Lymphoblastic Leukemia-Lymphoma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Glutamate receptor 1 Antibody
p21 Antibody (YA254)
AMPK beta 1 Antibody: AMPK beta 1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 30 kDa, targeting to AMPK beta 1. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts